Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian K Link

Showing results (41-50 of 231) with videos related to

Pageof 24
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Cyclophosphamide, vincristine, and prednisone followed by tositumomab and iodine-131-tositumomab in patients with untreated low-grade follicular lymphoma: eight-year follow-up of a multicenter phase II studyBrian K Link, Peter Martin, Mark S Kaminski, et al.
Seminars in Ophthalmology|December 14, 2004
Optic neuropathy due to anaplastic large cell lymphomaJames G Howard, Andrew G Lee, Mark Garwood, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin's lymphoma treated with chemotherapyShane D Scott, Elizabeth A Chrischilles, Brian K Link, et al.
JAAD Case Reports|October 27, 2018
Primary diffuse large B cell lymphoma of the vulva-Two new cases of a rare entity and review of the literatureAlice L Ye, Melissa S Willis, Brian K Link, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2016
Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody TherapyLaura M Rogers, Sarah L Mott, Brian J Smith, et al.
Journal of the American Academy of Dermatology|October 5, 2010
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphomaYoun H Kim, Michael Girardi, Madeleine Duvic, et al.
Leukemia & Lymphoma|July 19, 2017
Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval lengthEric M Ammann, Tait D Shanafelt, Kara B Wright, et al.
Blood Neoplasia|June 2, 2025
Optimal number of cycles of bendamustine as initial chemoimmunotherapy for older patients with follicular lymphomaChristopher S Strouse, Vanessa E Siebert, Bradley T Loeffler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Improved survival of follicular lymphoma patients in the United StatesWade T Swenson, James E Wooldridge, Charles F Lynch, et al.
Cancer Causes & Control : CCC|April 25, 2006
Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States)Shari Chen-Hardee, Elizabeth A Chrischilles, Margaret D Voelker, et al.
Pageof 24

Showing results (41-50 of 231) with videos related to

Sort By:
Pageof 24
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 12, 2010
Cyclophosphamide, vincristine, and prednisone followed by tositumomab and iodine-131-tositumomab in patients with untreated low-grade follicular lymphoma: eight-year follow-up of a multicenter phase II studyBrian K Link, Peter Martin, Mark S Kaminski, et al.
Seminars in Ophthalmology|December 14, 2004
Optic neuropathy due to anaplastic large cell lymphomaJames G Howard, Andrew G Lee, Mark Garwood, et al.
Journal of Managed Care Pharmacy : JMCP|November 14, 2003
Days of prophylactic filgrastim use to reduce febrile neutropenia in patients with non-Hodgkin's lymphoma treated with chemotherapyShane D Scott, Elizabeth A Chrischilles, Brian K Link, et al.
JAAD Case Reports|October 27, 2018
Primary diffuse large B cell lymphoma of the vulva-Two new cases of a rare entity and review of the literatureAlice L Ye, Melissa S Willis, Brian K Link, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 17, 2016
Complement-Regulatory Proteins CFHR1 and CFHR3 and Patient Response to Anti-CD20 Monoclonal Antibody TherapyLaura M Rogers, Sarah L Mott, Brian J Smith, et al.
Journal of the American Academy of Dermatology|October 5, 2010
Phase I trial of a Toll-like receptor 9 agonist, PF-3512676 (CPG 7909), in patients with treatment-refractory, cutaneous T-cell lymphomaYoun H Kim, Michael Girardi, Madeleine Duvic, et al.
Leukemia & Lymphoma|July 19, 2017
Updating survival estimates in patients with chronic lymphocytic leukemia or small lymphocytic lymphoma (CLL/SLL) based on treatment-free interval lengthEric M Ammann, Tait D Shanafelt, Kara B Wright, et al.
Blood Neoplasia|June 2, 2025
Optimal number of cycles of bendamustine as initial chemoimmunotherapy for older patients with follicular lymphomaChristopher S Strouse, Vanessa E Siebert, Bradley T Loeffler, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Improved survival of follicular lymphoma patients in the United StatesWade T Swenson, James E Wooldridge, Charles F Lynch, et al.
Cancer Causes & Control : CCC|April 25, 2006
Population-based assessment of hospitalizations for neutropenia from chemotherapy in older adults with non-Hodgkin's lymphoma (United States)Shari Chen-Hardee, Elizabeth A Chrischilles, Margaret D Voelker, et al.
Pageof 24